Mechanical testing of cephalomedullary nail lag screws after the addition of hydroxyapatite substitutes.
biomechanical · Level V
Where this comes from
- Record sourced from PubMed, PMID 34913029.
- Also identified by DOI 10.1097/OI9.0000000000000160 and PMC identifier 8670595.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To compare the effects of 3 implant designs, with and without hydroxyapatite reinforcement, on push/pull-out strength and rotational torque. Three implant designs (Gamma 3, INTERTAN, and PFNA-II) were selected for comparison. A hydroxyapatite cylinder (NEOBRACE) was used to reinforce the interface between the femoral head and the lag screw. Maximum push-out strength, maximum pull-out strength, and peak rotational torque were measured in cellular blocks mimicking osteoporotic cancellous bone, with and without NEOBRACE. In the push-out test, INTERTAN produced a significantly higher push-out strength in osteoporotic bone density cellular blocks than the other lag screws and blades (<i>P</i> < .05). With the addition of NEOBRACE, push-out strength was significantly higher for INTERTAN and PFNA-II (<i>P</i> < .05) than for the non-NEOBRACE group. In the pull-out test, INTERTAN produced a significantly higher pull-out strength in the osteoporotic bone density cellular blocks than did the other lag screws and blades (<i>P</i> < .05). With the addition of NEOBRACE, the pull-out strengths of INTERTAN and Gamma 3 versus those of the non-NEOBRACE group significantly increased (<i>P</i> < .05). In the rotational torque test, INTERTAN produced significantly greater rotational torque in the osteoporotic cellular blocks than the other lag screws and blades (<i>P</i> < .05). The addition of NEOBRACE resulted in a significant increase in rotational torque only for INTERTAN (<i>P</i> < .05). The use of NEOBRACE supported an increase in push/pull-out strength and rotational torque, especially in systems with a relatively increased bone or implant interface area.<b>Level of Evidence:</b> Level V.